Haoxi Health Technology Ltd
corporate_fare Company Profile
Haoxi Health Technology Ltd (NASDAQ:HAO) is a publicly traded company in the Trade & Services sector. Wiseek monitors HAO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Shareholders Approve Astronomical Share Capital Increase and Extreme Reverse Split Authorization
- Haoxi Health Seeks Shareholder Approval for Massive Capital Increase and Extreme Reverse Stock Split Authority
- CEO Invests $720K at Premium, Securing 83.83% Voting Power
- Haoxi Health Closes $6.46M Offering at 557% Premium to Market Price, Securing Critical Capital
- Haoxi Health Secures $6.46M in Registered Direct Offering at 5.5x Current Market Price, Addressing Going Concern
Financial Snapshot
Insider Transactions
HAO files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.